Aminoquinol: Spectrum and Tolerability
Aminoquinol is used to treat a range of protozoal infections. Its clinical spectrum includes giardiasis, cutaneous leishmaniasis, and toxoplasmosis.
- Mechanism: Inhibition of protein synthesis processes within pathogen cells.
- Safety: The drug is generally well tolerated by patients, but adverse effects such as nausea, general weakness, sleep disturbances like insomnia, tinnitus, and skin allergic reactions may occur.
- Management: If complications arise, dose reduction or temporary discontinuation of the medication is practiced.
Emetine Hydrochloride: Origin and Indications
Emetine hydrochloride is a natural alkaloid derived from the root of ipecac (Cephaelis ipecacuanha). Similar to aminoquinol, its key pharmacological mechanism is the inhibition of protein synthesis.
The primary indication for this agent is amebic dysentery. The drug demonstrates high efficacy during the acute intestinal manifestations of the disease. Parenteral administration of the drug is generally well tolerated by the body, but requires strict monitoring due to the risk of pronounced toxicity.
Pharmacokinetics and Toxicity of Emetine
A crucial feature of emetine is its pronounced capacity for accumulation (cumulation) in tissues and organs upon repeated administration.
- Due to the risk of accumulation, course treatment requires strict adherence to intervals between cycles: at least 7–10 days for the complete elimination of the substance from the body.
- Overdose and toxic effects manifest as vomiting, pain in the limbs (myalgia), polyneuritis, and signs of heart failure.
- If these symptoms appear, the drug must be discontinued immediately.